Target intelligence / Profile preview

Transient lower esophageal sphincter relaxation (TLESR)

Target
TLESR
01

Overview

Transient lower esophageal sphincter relaxation (TLESR) is a physiological event characterized by a sudden, spontaneous relaxation of the lower esophageal sphincter (LES) in the absence of swallowing[1][2][3]. TLESRs allow venting of gastric gas and are the main mechanism underpinning both belching and pathological gastroesophageal reflux, including reflux seen in gastroesophageal reflux disease (GERD)[1][2]. TLESRs typically last 10–45 seconds, significantly longer than swallow-induced LES relaxation, and are unrelated to basal LES pressure; they can be triggered by factors such as gastric distension[2][3]. Pharmacological efforts to reduce GERD symptoms have investigated modulation of TLESR frequency, with EP1 receptor antagonists, such as ONO-8539, shown to reduce the number of TLESRs in experimental settings[4]. This term refers to a physiological process or event—not to a molecule, protein, receptor, or conventional drug target. Thus, it is not considered a molecular therapeutic target and does not fit standard drug target classification schemas[1][2][3][4].

Other names
transient LES relaxationTLESRnon-swallow lower esophageal sphincter relaxation
02

Mechanism of action

Modulation of TLESR frequency (e.g., via EP1 receptor antagonism) to reduce gastroesophageal reflux.

03

Biological functions

Venting of gastric gasUnderpinning belchingUnderpinning pathological gastroesophageal reflux
04

Disease associations

Gastroesophageal reflux disease (GERD)
05

Interacting drugs

ONO-8539

Beyond the preview

Go deeper on Transient lower esophageal sphincter relaxation (TLESR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transient lower esophageal sphincter relaxation (TLESR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call